Navigation Links
Aperion Biologics Invited to Present at the UBS Global Life Sciences Conference
Date:9/16/2011

SAN ANTONIO, Sept. 16, 2011 /PRNewswire/ -- Aperion Biologics, Inc. announced today that the company will be presenting at the 2011 UBS Global Life Sciences Conference at the Grand Hyatt New York on Wednesday, September 21, 2011 at 3:00 PM (EDT).

Daniel Lee, Chief Executive Officer, is scheduled to present an overview of the Company's unique technology, clinical progress and plans for commercialization.

Interested parties may listen to the live webcast and view a copy of the slide presentations by visiting the "News/Events" section of the Company's web site at www.aperionbiologics.com.

About Aperion Biologics, Inc.

Aperion Biologics, Inc., located in San Antonio, Texas, is a privately owned, clinical-stage medical device company addressing the need for alternatives to human-based grafts with animal-based tissue technology. Aperion developed and patented a technique to make animal tissues compatible for challenging human applications. The core platform technology utilizes the Company's proprietary Z-Process™, which removes the key carbohydrate antigens from animal tissues followed by a unique conversion process that both stabilizes and sterilizes the tissue without affecting its biomechanical or biological properties. This creates functioning scaffolds capable of remodeling into healthy tissue. Aperion's Z-Process™ is applicable to a variety of tissues used in orthopaedic, cardiovascular, plastic, dermatologic, general and other surgical specialties. The company's lead product for ligament reconstruction procedures, the Z-Lig ACLR Device, is currently in clinical investigation and not commercially approved for sale in the United States or other markets.


'/>"/>
SOURCE Aperion Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CMC Biologics Adds 2,000 Liter Single-Use Bioreactor at its Copenhagen Manufacturing Facility
2. Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform
3. Amgen Announces PDUFA Date for XGEVA® Supplemental Biologics License Application
4. Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics
5. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
6. United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
7. Avaxia Biologics, Inc. Awarded BARDA Contract for Therapeutic Countermeasure to Help the Nation Respond to a Radiological Emergency
8. China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
9. Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
10. BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
11. Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017 The Global Nebulizers Market ... 8.2% over the next decade to reach approximately $1698.68 ... the market is witnessing include rapidly growing demand in ... advancements in nebulizer products and online marketing strategies by ... market is categorized into pneumatic nebulizers, ultrasonic nebulizers and ...
(Date:1/17/2017)... DUBLIN , Jan. 17, 2017  Jazz Pharmaceuticals ... first patient has been enrolled in a Phase 3 ... versus best supportive care (BSC) in the prevention of ... undergoing hematopoietic stem cell transplant (HSCT) who are at ... VOD.  The defibrotide clinical trial will be conducted across ...
(Date:1/17/2017)... -- According to a new market research report "Neural Network Software Market by ... and Region - Global Forecast to 2021" published by MarketsandMarkets, the market to ... at a Compound Annual Growth Rate (CAGR) of 33.2%. ... ... ...
Breaking Medicine Technology:
(Date:1/17/2017)... Angeles, CA (PRWEB) , ... January 17, 2017 ... ... and concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview ... and magical moments that help everyone endure and pass through tough times, Dr. ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... music enthusiasts at the National Association of Music Merchants (NAMM) winter trade show, ... 22, 2017. , Etymotic’s ER•4® has long been the gold standard for high-definition, ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... accredited, online continuing education for EMS and firefighting professionals, has released four new ... Solution. These new courses are taught live in an online classroom and meet ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... announced its partnership with Sigfox in the U.S.A. to offer Internet ... including new offerings on large-scale environmental sensor deployments such as monitoring solutions ...
(Date:1/17/2017)... ... 2017 , ... Livionex, Inc., a Silicon Valley healthcare company focused on treating ... its dental gel that shows significant reduction in plaque levels and gum inflammation and ... was conducted at the Beckman Laser Institute at UC Irvine and has been published ...
Breaking Medicine News(10 mins):